Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Get ahead with in-depth pharmaceutical competitive intelligence

Stay on top of the rapidly changing competitive landscape with detailed insight and intelligence on key industry, commercial, clinical, regulatory, and R&D events.

Master the marketplace

To succeed in the pharmaceutical marketplace, it’s vital to stay up to date with developments that can affect your business. Our competitive and market intelligence can give you all the credible, detailed information you need in one place.

What we offer

You can quickly access referenced information across global key industry developments in the pharmaceutical and medical technology markets with our easy-to-use solutions and expert analysts.

Build detailed competitive and market landscape analyses quickly, with access to global information on:

Drug and device development
Patient populations
Clinical trials
Drug and device patents
Market moving events
Patient-based sales forecasts

How it helps

We help you more accurately:

Prioritize pharmaceutical R&D spend by finding gaps and unmet needs through the analysis of competitors’ targets and R&D priorities
Understand disease epidemiology and disease sub-populations targeted in clinical development
Anticipate market changes through patent expiration tracking
Earmark who is entering or exiting your market via licensing or acquisition, as well as who is securing or providing funding
Project revenue for your pipeline and marketed drugs

Relevant products

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Scrip: industry news and insights

Key benefits:

Follow market developments
Go beyond the news
Hear from news makers

Biomedtracker: follow the drug development process

Track and assess key events that will impact a drug’s probability of technical success and approval.

Key benefits:

Stay up to date
Get ahead of the competition
Conference coverage

View all content

Scrip

India’s Top Court Tells Singhs To Come Up With Plan To Pay Daiichi, Uphold Nation’s ‘Honor’

By Penelope MacRae 22 Mar 2019

India’s Supreme Court has told Malvinder Singh and Shivinder Singh, once corporate billionaires, to work out a strategy within two weeks to pay Japanese drug giant Daiichi Sankyo a $500m arbitration award and "uphold the nation’s honor."

Topic Business strategies Deal trends

View article
Scrip

Price ‘Anchoring’? Zolgensma And The Art Of Managing Gene Therapy Sticker Shock

By Cathy Kelly 22 Mar 2019

Public statements by Novartis and Avexis suggest Zolgensma could be cost effective at a price up to $5m. Analysts expect $2m. The lower estimate is still stunning, but could it be considered reasonable by comparison?

Topic Drug review Drug approval

View article
Citeline, Sitetrove, Trialtrove, Pharmaprojects

Citeline: Global Clinical Trial Intelligence Solutions

12 Mar 2019

Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.

Topic Clinical trials Clinical trial optimization

Single report
Scrip

Bayer Bosses Beg Risk-Averse Europe To Rethink

By Kevin Grogan 07 Mar 2019

The German group believes it is going to be at the forefront of development in the cell and gene therapy space but is worried that Europe is failing to recognize the value that the pharma industry and its new technologies can create for society.

Topic Cell and gene therapy

View article
Scrip

Asia Deal Watch: Bharat Expands Its Vaccine Holdings By Buying GSKs Chiron Behring

By Anju Ghangurde 07 Mar 2019

Bharat hopes to expand international reach of Chiron Behring’s rabies vaccine. WuXi and Biolingus partner on sublingual delivery.

Topic Drug approval Business strategies

View article
Trialtrove

From STEP to PrEP

By Jonathan Slater 07 Mar 2019

In June 2016, all United Nations Member States pledged to end the AIDS epidemic as a public health threat by 2030 and signed up to time-bound targets.

Topic Drug development landscape Diseases

View infographic
Datamonitor Healthcare, Biomedtracker

Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets

By Michael Haydock 04 Mar 2019

Find out which market-moving events and catalysts to watch for during the Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.

Topic Drug approval Drug development landscape Drug review

Full video
Scrip

Daiichi Sankyo Realigns Japan R&D As Oncology Comes To Fore

By Ian Haydock 27 Feb 2019

Daiichi Sankyo unveils further restructuring moves, this time mainly in its R&D functions in Japan, as part of an ongoing strategic pivot towards oncology.

Topic Research

View article
Scrip

Big Pharma Defuses Drug Pricing Landmines On Capitol Hill

By Jessica Merrill 27 Feb 2019

Industry's top leaders weren't exactly eager to testify on Capitol Hill. Now they might be wondering why they waited so long. Seven pharma leaders avoided missteps during a Senate Finance Committee hearing on drug pricing Feb. 26.

Topic Drug review

View article
Biomedtracker, Meddevicetracker

Biomedtracker: Early 2019 Outlook Report Extract

26 Feb 2019

In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.

Topic Drug approval Drug review Medtech

Single report
Biomedtracker

Biomedtracker: Catalyst Roundup 2018 Q4

22 Feb 2019

A Review of Select Catalysts from Last Quarter’s Outlook Report.

Topic Clinical trials Drug approval Drug review Drug development landscape

View infographic
Scrip

Mortality Signal For Pfizers Xeljanz In Rheumatoid Arthritis Puts A Damper On JAK Class

By Emily Hayes 21 Feb 2019

Analyst speculates that risk of pulmonary embolism for a higher unapproved of Xeljanz in arthritis could trigger a label change for the same regimen in the drug's ulcerative colitis indication.

Topic Arthritis

View article
Scrip

Bayer Bags Full Vitrakvi Rights As Lilly Signs Off Loxo Buy

By Kevin Grogan 21 Feb 2019

When buying Loxo, Lilly highlighted the importance of LOXO-292, a first-in-class oral RET inhibitor, rather than the already-approved Vitrakvi, perhaps knowing that partner Bayer was going to be exercising an option to take full control of the TRK inhibitor.

View article
Scrip, Pink Sheet

Webinar: What’s the Reality of Real World Evidence?

By Mary Jo Laffler 19 Feb 2019

The data and analysis for this webinar were drawn from Pink Sheet and Scrip, both part of the Informa Pharma Intelligence suite of intelligence solutions.

Full video
Scrip

In NASH, Gilead Swung For The Fences And Struck Out Again

By Joseph Haas 14 Feb 2019

Gilead took a risky approach with selonsertib in NASH, pursuing a tough liver fibrosis benefit and failing, continuing a trend of disappointments outside of its antiviral franchises. Analysts don’t expect the second Phase III study in less-sick patients to succeed either.

Topic Drug review Drug approval Drug development landscape Clinical trials

View article

Latest headlines

Scrip

25 Mar 2019

Novartis’ Srinivasan On Putting Data Analytics To Use In Clinical Development

Link
Scrip

25 Mar 2019

Pipeline Watch: Phase III Readouts For Vibegron, Doria And Ameluz

Link
Scrip

22 Mar 2019

Obituary: James Diamond, Former ABPI President

Link
Scrip

22 Mar 2019

Finance Watch: Flagship Raises $824m To Speed Growth Of Its Portfolio Companies

Link
Scrip

22 Mar 2019

Tesaro's On The Right Path With Anti-PD-1 Dostarlimab In Endometrial Cancer

Link
Scrip

22 Mar 2019

Shionogi Stays The Course As It Lays Out R&D Priorities

Link
Scrip

22 Mar 2019

Alios Buy Best Forgotten For Johnson & Johnson As RSV Failure Costs It Dear

Link
Scrip

22 Mar 2019

Adios To Alcon In April As Novartis Confirms Spin-Off Date

Link
Scrip

21 Mar 2019

What Brexit Effect? UK Biotech Start-Ups Reach Record Numbers

Link
Scrip

21 Mar 2019

Why Biogen/Eisai's Aducanumab Failure Is Not The End Of Amyloid Hypothesis

Link
Scrip

21 Mar 2019

Executives On The Move: C4 Therapeutics Appoints A CMO, Innovio Pharma Brings In A COO, And A Departure At The Top For Sandoz

Link
Scrip

21 Mar 2019

Conatus Endures Another NASH Setback With Failure To Hit Fibrosis Endpoint

Link
Scrip

21 Mar 2019

INFOGRAPHIC: NASH Pipeline: Racing To The Finish

Link
Scrip

21 Mar 2019

Scandinavia Serves Up Two Partners For Alexion, In Its Rare Disease Sweet-Spot

Link
Scrip

20 Mar 2019

Merck KGAA/Pfizer Discontinue Phase III Avelumab/Talazoparib Combo Study In Ovarian Cancer

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Get ahead with in-depth pharmaceutical competitive intelligence

​Master the marketplace

Relevant products

Below are the Product List

Datamonitor Healthcare: data analysis and insight

Scrip: industry news and insights

Biomedtracker: follow the drug development process

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store

Master the marketplace